血脂异常作为1型糖尿病儿童动脉粥样硬化性心血管疾病预防的靶点:家族性高胆固醇血症的经验教训
本综述讨论1型糖尿病与家族性高胆固醇血症中血脂异常在动脉粥样硬化性心血管疾病发生中的作用。家族性高胆固醇血症儿童早期启动他汀治疗使动脉粥样硬化性心血管疾病风险显著下降;1型糖尿病患者死亡风险仍为一般人群的2至8倍, landmark研究均得出1型糖尿病个体动脉粥样硬化性心血管疾病风险显著增加的结论。综述认为家族性高胆固醇血症儿童早期启动他汀的经验可能为更严格管控1型糖尿病儿童血脂异常提供依据。
要点
- 家族性高胆固醇血症儿童早期启动他汀治疗使动脉粥样硬化性心血管疾病风险显著下降。
- 1型糖尿病个体死亡风险为一般人群的2至8倍。
- 多项landmark研究一致得出1型糖尿病个体动脉粥样硬化性心血管疾病风险显著增加。
核心结论
- 家族性高胆固醇血症儿童早期启动他汀使动脉粥样硬化性心血管疾病风险显著下降的经验,可能为更严格管控1型糖尿病儿童血脂异常提供依据。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- 近几十年来,家族性高胆固醇血症个体因儿童期早期启动他汀治疗,动脉粥样硬化性心血管疾病风险显著下降。
- 1型糖尿病个体死亡风险仍为一般人群的2至8倍。
- 近20年发表的关于1型糖尿病尤其年轻成人超额死亡的多项landmark研究,虽人群不同,均得出1型糖尿病个体动脉粥样硬化性心血管疾病风险显著增加的结论。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the last few decades, atherosclerotic cardiovascular disease (ASCVD) risk has decreased dramatically among individuals affected by familial hypercholesterolaemia (FH) as a result of the early initiation of statin treatment in childhood. Contemporaneously important improvements in care for people with diabetes have also been made, such as the prevention of mortality from acute diabetic complications. However, individuals with type 1 diabetes still have a two to eight times higher risk of death than the general population. In the last 20 years, a few landmark studies on excess mortality in people with type 1 diabetes, in particular young adults, have been published. Although these studies were carried out in different populations, all reached the same conclusion: individuals with type 1 diabetes have a pronounced increased risk of ASCVD. In this review, we address the role of lipid abnormalities in the development of ASCVD in type 1 diabetes and FH. Although type 1 diabetes and FH are different diseases, lessons could be learned from the early initiation of statins in children with FH, which may provide a rationale for more stringent control of dyslipidaemia in children with type 1 diabetes.
引用
- Corpeleijn WE, de Waal WJ, Schipper HS, et al. Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia. Diabetologia. 2023. PMID: 38032368. doi:10.1007/s00125-023-06041-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。